RE:RE:RE:RE:RE:RE:RE:RE:cxr price is too low , hostile takeover is imminent Be sure to research the following subjects:
donnatal fda approved?
Price gouging loophole exposed
debt to ebitda
lawsuits
generic competition
out of patent
firing on all cylinders
business performing as expected
asset write downs
overpaid
overleveraged
legacy pharma
cayman islands
margin call
scripts declining
private jet
$9 million salary
bagholder
cocaine
MoparHellcat wrote: The upside here for me looks great things i hope will work out for all of us here
still doing my research here before jumping in.